FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317831460> ?p ?o ?g. }

• W4317831460 abstract "Severe bronchiolitis is often associated with subsequent respiratory morbidity, mainly recurrent wheezing and asthma. However, the underlying immune mechanisms remain unclear. The main goal of this study was to investigate the association of nasal detection of periostin and thymic stromal lymphopoietin (TSLP) during severe bronchiolitis with the development of asthma at 4 years of age.Observational, longitudinal, post-bronchiolitis, hospital-based, follow-up study. Children hospitalized for bronchiolitis between October/2013 and July/2017, currently aged 4 years, included in a previous study to investigate the nasal airway secretion of TSLP and periostin during bronchiolitis, were included. Parents were contacted by telephone, and were invited to a clinical interview based on a structured questionnaire to obtain information on the respiratory evolution. The ISAAC questionnaire for asthma symptoms for 6-7-year-old children, was also employed.A total of 248 children were included (median age 4.4 years). The mean age at admission for bronchiolitis was 3.1 (IQR: 1.5-6.5) months. Overall, 21% had ever been diagnosed with asthma and 37% had wheezed in the last 12 months. Measurable nasal TSLP was detected at admission in 27(11%) cases and periostin in 157(63%). The detection of nasal TSLP was associated with the subsequent prescription of maintenance asthma treatment (p = 0.04), montelukast (p = 0.01), and the combination montelukast/inhaled glucocorticosteroids (p = 0.03). Admissions for asthma tended to be more frequent in children with TSLP detection (p = 0.07). In the multivariate analysis, adjusting for potential confounders, the detection of TSLP remained independently associated with chronic asthma treatment prescription (aOR:2.724; CI 1.051-7.063, p:0.04) and with current asthma (aOR:3.41; CI 1.20-9.66, p:0.02). Nasal detection of periostin was associated with lower frequency of ever use of short-acting beta2-agonists (SABA) (p = 0.04), lower prevalence of current asthma (p = 0.02), less prescription of maintenance asthma treatment in the past 12 months (p = 0.02, respectively). In the multivariate analysis, periostin was associated with lower risk of asthma at 4 years, independently of the atopic status (aOR:0.511 CI 95% 0.284-0.918, p:0.025).Our results show a positive correlation between nasal TSLP detection in severe bronchiolitis and the presence of current asthma, prescription of asthma maintenance treatment and respiratory admissions up to the age of 4 years. By contrast, we found a protective association between nasal periostin detection and current asthma at 4 years, ever diagnosis of asthma, maintenance asthma treatment prescription, and respiratory admissions." @default.
• W4317831460 created "2023-01-24" @default.
• W4317831460 creator A5019020069 @default.
• W4317831460 creator A5023676098 @default.
• W4317831460 creator A5025141275 @default.
• W4317831460 creator A5026532124 @default.
• W4317831460 creator A5045915290 @default.
• W4317831460 creator A5045993404 @default.
• W4317831460 creator A5076224742 @default.
• W4317831460 creator A5089604695 @default.
• W4317831460 creator A5090587709 @default.
• W4317831460 date "2023-01-24" @default.
• W4317831460 modified "2023-10-18" @default.
• W4317831460 title "Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age" @default.
• W4317831460 cites W1947232527 @default.
• W4317831460 cites W1963816367 @default.
• W4317831460 cites W1971057004 @default.
• W4317831460 cites W1973250128 @default.
• W4317831460 cites W1984066690 @default.
• W4317831460 cites W2009104438 @default.
• W4317831460 cites W2021701428 @default.
• W4317831460 cites W2043551932 @default.
• W4317831460 cites W2068274805 @default.
• W4317831460 cites W2100344886 @default.
• W4317831460 cites W2104037951 @default.
• W4317831460 cites W2110547872 @default.
• W4317831460 cites W2127825607 @default.
• W4317831460 cites W2128494153 @default.
• W4317831460 cites W2145377904 @default.
• W4317831460 cites W2145783587 @default.
• W4317831460 cites W2147516417 @default.
• W4317831460 cites W2158981664 @default.
• W4317831460 cites W2301746263 @default.
• W4317831460 cites W2314607884 @default.
• W4317831460 cites W2417998938 @default.
• W4317831460 cites W2474538279 @default.
• W4317831460 cites W2586345689 @default.
• W4317831460 cites W2586676015 @default.
• W4317831460 cites W2606076242 @default.
• W4317831460 cites W2610695687 @default.
• W4317831460 cites W2610988083 @default.
• W4317831460 cites W2809702058 @default.
• W4317831460 cites W2892221285 @default.
• W4317831460 cites W2948873023 @default.
• W4317831460 cites W2998478226 @default.
• W4317831460 cites W3000823447 @default.
• W4317831460 cites W3005820698 @default.
• W4317831460 cites W3048933115 @default.
• W4317831460 cites W3097109474 @default.
• W4317831460 cites W3103497413 @default.
• W4317831460 cites W3170686259 @default.
• W4317831460 cites W3187671110 @default.
• W4317831460 cites W3201366138 @default.
• W4317831460 cites W4200055072 @default.
• W4317831460 cites W4206678311 @default.
• W4317831460 cites W4210640671 @default.
• W4317831460 cites W4285593428 @default.
• W4317831460 cites W4296139401 @default.
• W4317831460 cites W980174965 @default.
• W4317831460 doi "https://doi.org/10.1186/s12931-023-02323-7" @default.
• W4317831460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36694181" @default.
• W4317831460 hasPublicationYear "2023" @default.
• W4317831460 type Work @default.
• W4317831460 citedByCount "0" @default.
• W4317831460 crossrefType "journal-article" @default.
• W4317831460 hasAuthorship W4317831460A5019020069 @default.
• W4317831460 hasAuthorship W4317831460A5023676098 @default.
• W4317831460 hasAuthorship W4317831460A5025141275 @default.
• W4317831460 hasAuthorship W4317831460A5026532124 @default.
• W4317831460 hasAuthorship W4317831460A5045915290 @default.
• W4317831460 hasAuthorship W4317831460A5045993404 @default.
• W4317831460 hasAuthorship W4317831460A5076224742 @default.
• W4317831460 hasAuthorship W4317831460A5089604695 @default.
• W4317831460 hasAuthorship W4317831460A5090587709 @default.
• W4317831460 hasBestOaLocation W43178314601 @default.
• W4317831460 hasConcept C126322002 @default.
• W4317831460 hasConcept C187212893 @default.
• W4317831460 hasConcept C189165786 @default.
• W4317831460 hasConcept C2776042228 @default.
• W4317831460 hasConcept C2776322731 @default.
• W4317831460 hasConcept C2777699602 @default.
• W4317831460 hasConcept C2778070265 @default.
• W4317831460 hasConcept C2778821649 @default.
• W4317831460 hasConcept C534529494 @default.
• W4317831460 hasConcept C71924100 @default.
• W4317831460 hasConcept C86803240 @default.
• W4317831460 hasConcept C95444343 @default.
• W4317831460 hasConceptScore W4317831460C126322002 @default.
• W4317831460 hasConceptScore W4317831460C187212893 @default.
• W4317831460 hasConceptScore W4317831460C189165786 @default.
• W4317831460 hasConceptScore W4317831460C2776042228 @default.
• W4317831460 hasConceptScore W4317831460C2776322731 @default.
• W4317831460 hasConceptScore W4317831460C2777699602 @default.
• W4317831460 hasConceptScore W4317831460C2778070265 @default.
• W4317831460 hasConceptScore W4317831460C2778821649 @default.
• W4317831460 hasConceptScore W4317831460C534529494 @default.
• W4317831460 hasConceptScore W4317831460C71924100 @default.
• W4317831460 hasConceptScore W4317831460C86803240 @default.
• W4317831460 hasConceptScore W4317831460C95444343 @default.
• W4317831460 hasFunder F4320324494 @default.

• next